中国地区层面社会经济不平等与死亡率:基于ChinaHEART项目的全国队列研究
该研究基于ChinaHEART全国队列,纳入2015年12月至2022年12月453个区县35-75岁居民1,119,027人,中位随访4.5年。与高地区社会经济地位相比,低地区社会经济地位与全因死亡(HR 1.11,95%CI 1.07-1.16)、心血管病死亡(HR 1.38,95%CI 1.29-1.48)和呼吸系统疾病死亡(HR 1.44,95%CI 1.22-1.71)风险升高显著相关,个体层面因素中介了39.5%的关联。
要点
- 低地区社会经济地位与全因死亡风险升高相关(HR 1.11,95%CI 1.07-1.16)。
- 低地区社会经济地位与心血管病死亡(HR 1.38)和呼吸系统疾病死亡(HR 1.44)风险升高相关。
- 个体层面社会经济、行为和代谢因素中介了39.5%的关联。
核心结论
- 中国存在显著的地区层面社会经济地位相关死亡率不平等,个体层面社会经济、行为和代谢因素起中介作用。
- 作者认为需要采取行动改善地区层面环境和个人因素以促进健康公平。
研究设计与样本
- 全国队列研究,纳入453个区县35-75岁居民1,119,027人,平均年龄56.1岁(SD 9.9),女性672,385人(60.1%)。
- 地区层面社会经济地位综合值由全国人口普查数据生成并分为三分位。
- 采用Clopper-Pearson法计算死亡率及95%CI,Cox frailty模型计算调整HR及95%CI,并评估个体因素的中介作用。
主要发现
- 2015年12月至2022年12月纳入参与者,中位随访4.5年期间发生24,426例死亡(5.24/1000人年,95%CI 5.18-5.31)。
- 与高地区社会经济地位相比,低地区社会经济地位与全因死亡风险升高显著相关(HR 1.11,95%CI 1.07-1.16)。
- 与高地区社会经济地位相比,低地区社会经济地位与心血管病死亡风险升高显著相关(HR 1.38,95%CI 1.29-1.48)。
- 与高地区社会经济地位相比,低地区社会经济地位与呼吸系统疾病死亡风险升高显著相关(HR 1.44,95%CI 1.22-1.71)。
- 年龄大于60岁、女性及个体层面社会经济地位较低的参与者中关联更强;个体层面社会经济、行为和代谢因素中介了39.5%的关联,其中个体层面社会经济地位贡献最大。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Socioeconomic status is a key social determinant of health. Compared with individual-level socioeconomic status, the association between area-level socioeconomic status and mortality has not been well investigated in China. We aimed to assess associations between area-level socioeconomic status and all-cause mortality and cause-specific mortality in China, as well as the interplay of area-level and individual-level socioeconomic status on mortality. METHODS: In this nationwide cohort study, residents aged 35-75 years from 453 districts and counties were included in the China Health Evaluation and Risk Reduction Through Nationwide Teamwork (ChinaHEART) Study. The composite value of area-level socioeconomic status was generated from national census data and categorised into tertiles. Mortality rates and their 95% CIs were calculated using the Clopper-Pearson method. Cox frailty models were fitted to calculate adjusted hazard ratios and 95% CIs for area-level socioeconomic status with the risk of all-cause mortality and cause-specific mortality and their disparities across different population. We also assessed the roles of multiple individual factors as potential mediators. FINDINGS: Between December, 2015, and December, 2022, 1 119 027 participants were included, for whom the mean age was 56·1 (SD 9·9) years and 672 385 (60·1%) were female. 24 426 (5·24 [95% CI 5·18-5·31] per 1000 person-years) deaths occurred during the median 4·5-year follow-up. Compared with high area-level socioeconomic status, low area-level socioeconomic status was significantly associated with an increased risk of all-cause (hazard ratio 1·11, 95% CI 1·07-1·16), cardiovascular disease (1·38, 1·29-1·48), and respiratory disease (1·44, 1·22-1·71) mortality. The stronger associations were observed in people older than 60 years, females, and participants with lower individual-level socioeconomic status. The individual-level socioeconomic, behavioural, and metabolic factors mediated 39·5% of the association between area-level socioeconomic status and mortality, of which individual-level socioeconomic status made the largest contribution. INTERPRETATION: There are substantial area-level socioeconomic status-related inequalities in mortality in China. Individual-level socioeconomic, behavioural, and metabolic factors had mediating effects. Actions to improve area-level circumstances and individual factors are needed to improve health equity. FUNDING: The Chinese Academy of Medical Sciences Innovation Fund for Medical Science, the National High Level Hospital Clinical Research Funding, the Ministry of Finance of China, and the National Health Commission of China. TRANSLATION: For the Chinese translation of the abstract see Supplementary Materials section.
引用
- Peng W, Lin S, Chen B, et al. Area-level socioeconomic inequalities in mortality in China: a nationwide cohort study based on the ChinaHEART project. Lancet Public Health. 2024. PMID: 39419059. doi:10.1016/S2468-2667(24)00154-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。